natgillin/translations-raw huggingface dataset:
Having regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC [1], and in particular Article 59(9) thereof,
ob upoštevanju Uredbe (ES) št. 1907/2006 Evropskega parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH) ter o ustanovitvi Evropske agencije za kemikalije in o spremembi Direktive 1999/45/ES ter o razveljavitvi Uredbe Sveta (EGS) št. 793/93 in Uredbe Komisije (ES) št. 1488/94 ter Direktive Sveta 76/769/EGS in direktiv Komisije 91/155/EGS, 93/67/EGS, 93/105/ES in 2000/21/ES [1] ter zlasti člena 59(9) Uredbe,
Bis(2-ethylhexyl) phthalate (DEHP), (EC No 204-211-0, CAS No 117-81-7), dibutyl phthalate (DBP) (EC No 201-557-4, CAS No 84-74-2), benzyl butyl phthalate (BBP) (EC No 201-622-7, CAS No 85-68-7) and diisobutyl phthalate (DIBP) (EC No 201-553-2, CAS No 84-69-5) are included in the candidate list referred to in Article 59(1) of Regulation (EC) No 1907/2006 as substances toxic for reproduction (category 1B) according to Article 57(c) of that Regulation.
Bis(2-etilheksil) ftalat (DEHP) (št.
Those substances are also listed in Annex XIV to that Regulation.
EC 204-211-0, št.
In accordance with Article 59(3) of Regulation (EC) No 1907/2006, on 26 August 2014 Denmark submitted to the European Chemicals Agency (hereinafter referred to as ‘the Agency’) four dossiers in accordance with Annex XV to that Regulation (hereinafter referred to as ‘Annex XV dossiers’) for the identification of DEHP, DBP, BBP and DIBP as substances of very high concern under Article 57(f) of that Regulation due to their endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health or the environment which give rise to an equivalent level of concern to those of other substances listed in paragraphs (a) to (e) of Article 57.
CAS 117-81-7), dibutil ftalat (DBP) (št.
When the four Annex XV dossiers were considered by the Member State Committee of the Agency (‘MSC’), they were considered in two parts each, one covering the human health aspects and the other covering the environmental aspects of the dossier, respectively.
EC 201-557-4, št.
As for the Annex XV dossiers for DBP, BBP and DIBP, the dossier submitter subsequently withdrew the part of its proposal concerning identification of these substances as having endocrine disrupting properties whose effects in relation to the environment give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006, in order to further elaborate on the justifications provided in the documentation.
CAS 84-74-2) in benzilbutil ftalat (BBP) (št.
On 11 December 2014 the MSC adopted its opinions [2] on the remaining part of the Annex XV dossiers.
EC 201-622-7, št.
The MSC reached a unanimous agreement on the identification of DEHP as having endocrine disrupting properties for which there is scientific evidence of probable serious effects to the environment which give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006.
CAS 85-68-7) in diizobutil ftalat (DIBP) (št. EC 201-553-2, št.
Accordingly the Agency amended the DEHP entry in the candidate list on 17 December 2014.
CAS 84-69-5) so vključeni na seznam kandidatnih snovi iz člena 59(1) Uredbe (ES) št. 1907/2006 kot snovi, strupene za razmnoževanje (kategorija 1B), v skladu s členom 57(c) navedene uredbe.
The MSC unanimously acknowledged that for DEHP, BBP, DBP and DIBP there is scientific evidence on the endocrine activity and on the link between this activity and the adverse effects to human health and further, that the substances can be considered endocrine disruptors for human health as they fulfil the WHO/IPCS definition for an endocrine disruptor and the recommendations from the European Commission's Expert Advisory Group for a substance to be identified as an endocrine disruptor.
Navedene snovi so tudi na seznamu v Prilogi XIV k navedeni uredbi.
However, the MSC did not reach unanimous agreement on the identification of the four substances under Article 57(f) of Regulation (EC) No 1907/2006 as giving rise to an equivalent level of concern to those of other substances listed in points (a) to (c) of that Article due to endocrine disrupting properties in relation to human health.
V skladu s členom 59(3) Uredbe (ES) št. 1907/2006 je Danska 26. avgusta 2014 Evropski agenciji za kemikalije (v nadaljnjem besedilu: Agencija) predložila štiri dokumentacije v skladu s Prilogo XV k navedeni uredbi (v nadaljnjem besedilu: dokumentacije v skladu s Prilogo XV) za identifikacijo DEHP, DBP, BBP in DIBP kot snovi, ki vzbujajo veliko zaskrbljenost, na podlagi člena 57(f) navedene uredbe zaradi njihovih lastnosti endokrinih motilcev, za katere obstajajo znanstveni dokazi o verjetnih resnih učinkih na zdravje ljudi ali okolje, ki vzbujajo enakovredno raven zaskrbljenosti kot ostale snovi iz odstavkov od (a) do (e) člena 57.
According to four members of the MSC the effects for human health pointed out in the Annex XV dossiers were the same effects, caused by the same mode of action, as those already taken into account when the substances were included in the candidate list due to their toxicity for reproduction according to Article 57(c) of that Regulation.
Ko je Odbor držav članic Agencije (v nadaljnjem besedilu: odbor) obravnaval štiri dokumentacije v skladu s Prilogo XV, je bila vsaka dokumentacija obravnavana v dveh delih, pri čemer je en del zajemal vidike o zdravju ljudi, drugi pa vidike o okolju iz dokumentacije.
On 20 February 2015, pursuant to Article 59(9) of Regulation (EC) No 1907/2006, the MSC referred its opinion to the Commission for a decision on the identification of the four substances as having endocrine disrupting properties for human health giving rise to an equivalent level of concern according to Article 57(f).
Glede dokumentacij v skladu s Prilogo XV za DBP, BBP in DIBP so vložniki dokumentacij naknadno umaknili del svojega predloga glede identifikacije teh snovi kot snovi z lastnostmi endokrinih motilcev, katerih posledice za okolje vzbujajo enakovredno raven zaskrbljenosti v skladu s členom 57(f) Uredbe (ES) št. 1907/2006, da so izpopolnili utemeljitve iz dokumentacije.
The Commission notes the unanimous agreement in MSC that the four substances have endocrine disrupting properties and that the adverse effects caused by this mode of action are the same effects that led to their classification as toxic for reproduction and their identification as substances of very high concern according to Article 57(c) of Regulation (EC) No 1907/2006.
Odbor je 11. decembra 2014 sprejel mnenja [2] o preostalem delu dokumentacij v skladu s Prilogo XV.
The Commission also notes that the majority of members of the MSC considered that the level of concern of those effects is equivalent to those of substances referred to in Article 57(a) to (e).
Odbor je sprejel soglasno odločitev o identifikaciji DEHP kot snovi z lastnostmi endokrinih motilcev, za katero obstajajo znanstveni dokazi o verjetnih resnih učinkih na okolje, ki vzbujajo enakovredno raven zaskrbljenosti v skladu s členom 57(f) Uredbe (ES) št. 1907/2006.
The Commission notes that Article 57 does not preclude identifying a substance as being of very high concern several times based on more than one intrinsic property causing the same effect on human health.
Agencija je zato 17. decembra 2014 spremenila vnos za DEHP na seznamu kandidatnih snovi.
Therefore DEHP, BBP, DBP and DIBP should be identified under Article 57(f) as substances of very high concern due to their endocrine disrupting properties for which there is scientific evidence of probable serious effects to human health which give rise to an equivalent level of concern to those of other substances listed in paragraph(s) (a) to (e) of that Article.
Odbor je soglasno priznal, da za DEHP, BBP, DBP in DIBP obstajajo znanstveni dokazi o njihovi motnji endokrine funkcije ter o vzročni zvezi med to funkcijo in škodljivim učinkom na zdravje ljudi, in dodal, da se te snovi lahko štejejo kot endokrini motilci za zdravje ljudi, saj izpolnjujejo opredelitev SZO/MPKV za endokrini motilec in priporočila strokovne svetovalne skupine Evropske komisije za identifikacijo snovi kot endokrini motilec.
This Decision is without prejudice to the outcome of the on-going activities related to the definition of criteria for the identification of endocrine disruptors in accordance with the provisions of Regulation (EC) No 1107/2009 of the European Parliament and of the Council [3], and Regulation (EU) No 528/2012 of the European Parliament and of the Council [4].
Vendar odbor ni dosegel soglasne odločitve o tem, ali se te štiri snovi lahko v skladu s členom 57(f) Uredbe (ES) št. 1907/2006 identificirajo kot snovi, ki vzbujajo enakovredno raven zaskrbljenosti kot ostale snovi iz točk od (a) do (c) navedenega člena zaradi njihovih lastnostih endokrinih motilcev v zvezi z zdravjem ljudi.
The measures provided for in this Decision are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,
Po mnenju štirih članov odbora so učinki na zdravje ljudi, obravnavani v dokumentaciji v skladu s Prilogo XV, enaki in posledica istega načina delovanja kot učinki, ki so že bili upoštevani, ko so bile snovi vključene na seznam kandidatnih snovi zaradi njihove strupenosti za razmnoževanje v skladu s členom 57(c) navedene uredbe.
HAS ADOPTED THIS DECISION:
Odbor je 20. februarja 2015 v skladu s členom 59(9) Uredbe (ES) št. 1907/2006 sporočil svoje mnenje Komisiji za sprejetje odločitve o identifikaciji štirih snovi kot snovi z lastnostmi endokrinih motilcev za zdravje ljudi, ki vzbujajo enako raven zaskrbljenosti v skladu s členom 57(f).
Sole Article
Komisija je seznanjena s soglasno odločitvijo odbora, da imajo štiri snovi lastnosti endokrinih motilcev in da so škodljivi učinki zaradi takega delovanja enaki kot učinki, zaradi katerih so bile razvrščene kot strupene za razmnoževanje in identificirane kot snovi, ki vzbujajo veliko zaskrbljenost v skladu s členom 57(c) Uredbe (ES) št. 1907/2006.
The following substances are identified as substances having endocrine disrupting properties whose effects to human health give rise to an equivalent level of concern according to Article 57(f) of Regulation (EC) No 1907/2006:
Komisija ugotavlja tudi, da je večina članov odbora menila, da je raven zaskrbljenosti zaradi navedenih učinkov enakovredna tisti pri snoveh iz člena 57(a) do (e).
Bis(2-ethylhexyl) phthalate (DEHP), (EC No 204-211-0, CAS No 117-81-7)
Komisija ugotavlja, da člen 57 ne izključuje večkratne identifikacije neke snovi kot snovi, ki vzbuja veliko zaskrbljenost, na podlagi več kot ene intrinzične lastnosti, ki povzroča isti učinek na zdravje ljudi.
Dibutyl phthalate (DBP) (EC No 201-557-4, CAS No 84-74-2)
Zato bi bilo treba DEHP, BBP, DBP in DIBP v skladu s členom 57(f) identificirati kot snovi, ki vzbujajo veliko zaskrbljenost zaradi njihovih lastnosti endokrinih motilcev, za katere obstajajo znanstveni dokazi o verjetnih resnih učinkih na zdravje ljudi, ki vzbujajo enakovredno raven zaskrbljenosti kot pri ostalih snoveh iz odstavkov od (a) do (e) navedenega člena.
Benzyl butyl phthalate (BBP) (EC No 201-622-7, CAS No 85-68-7)
Ta sklep ne posega v izid tekočih dejavnosti v zvezi z opredelitvijo meril za identifikacijo endokrinih motilcev v skladu z določbami Uredbe (ES) št. 1107/2009Evropskega parlamenta in Sveta [3] ter Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta [4].
Diisobutyl phthalate (DIBP) (EC No 201-553-2, CAS No 84-69-5)
Ukrepi iz tega sklepa so v skladu z mnenjem Odbora, ustanovljenega s členom 133 Uredbe (ES) št. 1907/2006 –
The entry of the substances specified in paragraph 1 in the candidate list referred to in Article 59(1) of Regulation (EC) No 1907/2006 shall be amended by adding, under ‘Reason for inclusion’, ‘Equivalent level of concern having probable serious effects to human health’.
SPREJELA NASLEDNJI SKLEP:
This Decision is addressed to the European Chemicals Agency.
Edini člen
Done at Brussels, 4 July 2017.
Naslednje snovi se identificirajo kot snovi z lastnostmi endokrinih motilcev, katerih posledice za zdravje ljudi vzbujajo enakovredno raven zaskrbljenosti v skladu s členom 57(f) Uredbe (ES) št. 1907/2006:
For the Commission
bis(2-etilheksil) ftalat (DEHP) (št.
Member of the Commission
EC 204-211-0, št.
OJ L 396, 30.12.2006, p. 1.
CAS 117-81-7),
Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1).
dibutil ftalat (DBP) (št.
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1).
EC 201-557-4, št.
Commission Implementing Decision (EU) 2017/1211
Izvedbeni sklep Komisije (EU) 2017/1211
authorising the placing on the market of products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
o odobritvi dajanja na trg proizvodov, ki vsebujejo gensko spremenjeni bombaž 281-24-236 × 3006-210-23 × MON 88913 (DAS-24236-5 × DAS-21Ø23-5 × MON-88913-8), so iz njega sestavljeni ali proizvedeni, v skladu z Uredbo (ES) št. 1829/2003 Evropskega parlamenta in Sveta
(notified under document C(2017) 4495)
(notificirano pod dokumentarno številko C(2017) 4495)
Having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed [1], and in particular Article 7(3) and Article 19(3) thereof,
ob upoštevanju Uredbe (ES) št. 1829/2003 Evropskega parlamenta in Sveta z dne 22. septembra 2003 o gensko spremenjenih živilih [1] in krmi ter zlasti členov 7(3) in 19(3) Uredbe,
On 12 March 2009, Dow AgroSciences Europe submitted to the competent authority of The Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from 281-24-236 × 3006-210-23 × MON 88913 cotton.
Družba Dow AgroSciences Europe je 12. marca 2009 v skladu s členoma 5 in 17 Uredbe (ES) št. 1829/2003 pristojnemu organu Nizozemske predložila vlogo za dajanje na trg živil, živilskih sestavin in krme, ki vsebujejo bombaž 281-24-236 × 3006-210-23 × MON 88913, so iz njega sestavljeni ali proizvedeni.
The application also covers the placing on the market of 281-24-236 × 3006-210-23 × MON 88913 cotton in products consisting of it or containing it for any other uses than food and feed as any other cotton, with the exception of cultivation.
Vloga zajema tudi dajanje na trg bombaža 281-24-236 × 3006-210-23 × MON 88913 v proizvodih, ki so iz njega sestavljeni ali ga vsebujejo ter se, razen kot živila in krma, uporabljajo kot kateri koli drugi bombaž, razen za gojenje.
On 8 April 2016, the European Food Safety Authority (‘EFSA’) issued a favourable opinion [3] in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003.
Evropska agencija za varnost hrane (v nadaljnjem besedilu: EFSA) je 8. aprila 2016 dala pozitivno mnenje [3] v skladu s členoma 6 in 18 Uredbe (ES) št. 1829/2003.
It concluded that genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 is as safe and as nutritious as its conventional counterpart in the context of its intended uses.
Ugotovila je, da je gensko spremenjeni bombaž 281-24-236 × 3006-210-23 × MON 88913 enako varen in hranljiv kot konvencionalen bombaž v okviru predvidenih vrst uporabe.
In its opinion, EFSA also concluded that the environmental monitoring plan, consisting of a general surveillance plan, submitted by the applicant is in line with the intended uses of the products.
EFSA je v mnenju tudi ugotovila, da je načrt spremljanja okolja, sestavljen iz splošnega načrta spremljanja, ki ga je predložil vložnik, v skladu s predvideno uporabo proizvodov.
Taking into account those considerations, authorisation should be granted to the products containing, consisting of, or produced from genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913.
Ob upoštevanju navedenih pomislekov bi bilo treba odobriti proizvode, ki vsebujejo gensko spremenjeni bombaž 281-24-236 × 3006-210-23 × MON 88913, so iz njega sestavljeni ali proizvedeni.
A unique identifier should be assigned to genetically modified cotton 281-24-236 × 3006-210-23 × MON 88913 in accordance with Commission Regulation (EC) No 65/2004 [4].
V skladu z Uredbo Komisije (ES) št. 65/2004 [4] bi bilo treba gensko spremenjenemu bombažu 281-24-236 × 3006-210-23 × MON 88913 dodeliti posebni identifikator.
On the basis of the EFSA opinion, no specific labelling requirements other than those provided for in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from cotton 281-24-236 × 3006-210-23 × MON 88913.
Na podlagi mnenja agencije EFSA za živila, živilske sestavine in krmo, ki vsebujejo bombaž 281-24-236 × 3006-210-23 × MON 88913, so iz njega sestavljeni ali proizvedeni, niso potrebne nobene druge zahteve za označevanje, razen zahtev iz členov 13(1) in 25(2) Uredbe (ES) št. 1829/2003.
However, in order to ensure the use of the products containing or consisting of cotton 281-24-236 × 3006-210-23 × MON 88913 within the limits of the authorisation provided for by this Decision, the labelling of those products, with the exception of food products, should be complemented by a clear indication that the products in question must not be used for cultivation.
Da se zagotovi uporaba proizvodov, ki vsebujejo bombaž 281-24-236 × 3006-210-23 × MON 88913 ali so iz njega sestavljeni, v okviru omejitev odobritve na podlagi tega sklepa, bi morala biti na oznakah navedenih proizvodov dodana jasna navedba, da se zadevni proizvodi ne smejo uporabljati za gojenje.
The EFSA opinion does not justify the imposition of specific conditions or restrictions for the placing on the market and/or of specific conditions or restrictions for the use and handling, including post-market monitoring requirements for the use of the food and feed, or of specific conditions for the protection of particular ecosystems/environment and/or geographical areas, as provided for in Article 6(5)(e) and Article 18(5)(e) of Regulation (EC) No 1829/2003.
Na podlagi mnenja agencije EFSA ni utemeljena uvedba posebnih pogojev ali omejitev pri dajanju na trg in/ali posebnih pogojev ali omejitev pri uporabi in ravnanju, vključno z zahtevami za spremljanje uporabe živila in krme po dajanju na trg, ali posebnih pogojev za varstvo posebnih ekosistemov/okolja in/ali geografskih območij v skladu s členoma 6(5)(e) in 18(5)(e) Uredbe (ES) št. 1829/2003.
All relevant information on the authorisation of the products should be entered in the Community register of genetically modified food and feed referred to in Regulation (EC) No 1829/2003.
Vse ustrezne informacije o odobritvi proizvodov bi bilo treba vnesti v register Skupnosti za gensko spremenjena živila in krmo iz Uredbe (ES) št. 1829/2003.
Genetically modified cotton (Gossypium hirsutum L.) 281-24-236 × 3006-210-23 × MON 88913, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier DAS-24236-5×DAS-21Ø23-5×MON-88913-8, in accordance with Regulation (EC) No 65/2004.
Gensko spremenjenemu bombažu (Gossypium hirsutum L.) 281-24-236 × 3006-210-23 × MON 88913, kakor je opredeljen v točki (b) Priloge k temu sklepu, se v skladu z Uredbo (ES) št. 65/2004 dodeli posebni identifikator DAS-24236-5×DAS-21Ø23-5×MON-88913-8.
The following products are authorised for the purposes of Article 4(2) and Article 16(2) of Regulation (EC) No 1829/2003 in accordance with the conditions set out in this Decision:
Za namene členov 4(2) in 16(2) Uredbe št.
foods and food ingredients containing, consisting of, or produced from DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton;
(ES) št. 1829/2003 se pod pogoji iz tega sklepa odobrijo naslednji proizvodi:
feed containing, consisting of, or produced from DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton;
živila in živilske sestavine, ki vsebujejo bombaž DAS-24236-5×DAS-21Ø23-5×MON-88913-8, so iz njega sestavljeni ali proizvedeni;
DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton in products containing it or consisting of it for any other use than (a) and (b), with the exception of cultivation.
krma, ki vsebuje bombaž DAS-24236-5×DAS-21Ø23-5×MON-88913-8, je iz njega sestavljena ali proizvedena;
Article 3
bombaž DAS-24236-5×DAS-21Ø23-5×MON-88913-8 v proizvodih, ki ga vsebujejo ali so iz njega sestavljeni ter se uporabljajo drugače, kot je navedeno v točkah (a) in (b), razen za gojenje.
Labelling
Člen 3
For the purposes of the labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003 of the European Parliament and of the Council [6], the ‘name of the organism’ shall be ‘cotton’.
Označevanje
The words ‘not for cultivation’ shall appear on the label of and in the documents accompanying products containing or consisting of DAS-24236-5×DAS-21Ø23-5×MON-88913-8 cotton with the exception of the products referred to in point (a) of Article 2.
Za namene zahtev za označevanje iz členov 13(1) in 25(2) Uredbe (ES) št. 1829/2003 ter člena 4(6) Uredbe (ES) št. 1830/2003 Evropskega parlamenta in Sveta [6] je „ime organizma“ „bombaž“.
Article 4
Proizvodi, ki vsebujejo bombaž DAS-24236-5×DAS-21Ø23-5×MON-88913-8 ali so iz njega sestavljeni, in dokumenti, priloženi tem proizvodom, se označijo z besedami „ni za gojenje“, z izjemo proizvodov iz točke (a) člena 2.
Monitoring for environmental effects
Člen 4
The authorisation holder shall ensure that the monitoring plan for environmental effects, as set out in point (h) of the Annex, is put in place and implemented.
Spremljanje učinkov na okolje
The authorisation holder shall submit to the Commission annual reports on the implementation and the results of the activities set out in the monitoring plan in accordance with the format set out in Decision 2009/770/EC.
Imetnik odobritve zagotovi, da se sprejme in izvaja načrt spremljanja učinkov na okolje iz točke (h) Priloge.
Article 5
Imetnik odobritve predloži Komisiji letna poročila o izvajanju in rezultatih dejavnosti iz načrta spremljanja v skladu z zahtevami iz Odločbe 2009/770/ES.
Community register
Člen 5
The information set out in the Annex to this Decision shall be entered in the Community register of genetically modified food and feed referred to in Article 28 of Regulation (EC) No 1829/2003.
Register Skupnosti
Article 6
Informacije iz Priloge k temu sklepu se vnesejo v register Skupnosti za gensko spremenjena živila in krmo iz člena 28 Uredbe (ES) št. 1829/2003.
Authorisation holder
Člen 6
The authorisation holder shall be Dow AgroSciences Europe, United Kingdom, representing Mycogen Seeds, United States.
Imetnik odobritve
Article 7
Imetnik odobritve je družba Dow AgroSciences Europe, Združeno kraljestvo, kot predstavnik družbe Mycogen Seeds, Združene države.
Validity
Člen 7
This Decision shall apply for a period of 10 years from the date of its notification.
Veljavnost
Article 8
Ta sklep se uporablja deset let od datuma uradnega obvestila.
Addressee
Člen 8